Health Condition 1: K80- Cholelithiasis Health Condition 2: K35-K38- Diseases of appendix Health Condition 3: N88- Other noninflammatory disorders ofcervix uteri Health Condition 4: N70- Salpingitis and oophoritis
Conditions
Sponsors
CMR Surgical Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient deemed suitable for at least one of the surgical procedures using Versius 2. Patients (or appropriate legal representatives) able to provide written and audio-visual informed consent to participate in the study 3. Male or female, aged between 18 and 65 years old 4. If female of childbearing potential, must not be pregnant and agree to not become pregnant for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Patient participation in an investigational clinical study within 30 days before screening 2. Inability to provide informed consent 3. Uncontrolled hypertension and/or diabetes mellitus 4. Patients who fall into New York Heart Association (NYHA) Class III or IV (Appendix B) 5. Incidence of metastases, regional and/or distant 6. History of chronic alcohol or drug abuse 7. Chronic renal failure or on dialysis 8. Significant medical history or immunocompromised 9. Subjects with any other clinically significant unstable medical disorder, life-threatening disease, or anything else in the opinion of the Investigator which would contra-indicate a surgical procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of unplanned conversion of procedures to other MAS or open surgeryTimepoint: Hopsitalisation Visit | — |
Secondary
| Measure | Time frame |
|---|---|
| The following parameters will be collected during the study: Operative time â?? from incision to skin closure Estimated blood loss (intra-operative) Blood transfusion (intra-operative) Return to operating room within 24 hours Length of hospital stay Readmission to hospital within 30 days Intra-operative complications Post-operative complications through 90 days, reported using Clavien-Dindo Classification (Dindo, 2004) (Appendix D) 90 day mortalityTimepoint: Study duration | — |
Countries
India
Contacts
Public ContactManisha Jadhav
Deenanath Mangeshkar Hospital & Research Centre
Outcome results
None listed